Cathelicidin peptide

LL-37

LL-37 is a human cathelicidin peptide studied in innate immunity. The cited work examines leukocyte chemotaxis and receptor-dependent calcium signaling.

Quantity per vial

Select variantCompare prices and choose a variant to set the quantity and add it to your quote.

Subtotal excludes freight and taxes. Availability and final terms are confirmed in the quote. Commercial and shipping terms

Mechanism and findings

In vitro · Study formulation · Human leukocytes and transfected cells

Cell migration

LL-37 induced chemotaxis and calcium mobilization in cellular assays involving FPRL1.

De et al., 2000 →

Literature findings; refer to the model and formulation studied.

Mechanism of action

LL-37 — cathelicidin peptide. The literature identity must be matched to the documented chemical form and composition of the supplied material.

LL-37 induced calcium mobilization and chemotaxis in human monocytes and FPRL1-transfected cells. The work links receptor recognition to leukocyte recruitment, distinguishing immune signaling from a clinical claim to treat infections.

  • FPRL1 / FPR2

De et al., 2000

Studied findings 1
In vitro · Study formulation

Cell migration

Human leukocytes and transfected cells

LL-37 induced chemotaxis and calcium mobilization in cellular assays involving FPRL1.

View context
Study design
Original-study abstract; experimental design described in linked source
Sample scope / arm
Not extracted; consult original study
Comparator
See original-study context
Experimental context (not instructions for use)
Abstract-level extraction; full methods and tables still require review.
Source section / table / abstract
Abstract

Evidence concerns the studied material and model, not the supplied BLOPEP batch.

De et al., 2000

Sources and studies 1
  1. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.

    De Yang, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, Oppenheim JJ, Chertov O · 2000 · The Journal of experimental medicine

    DOI: 10.1084/jem.192.7.1069

Specifications and packaging

Nominal variant content; analytical results belong to the documented batch.

Material type
Peptide

Quality and analyses

Review specifications, analytical results and documentation for published batches.

Purity
>99%
Type
Declared specification

Published batches

Batch results have not yet been published on this page.

Storage

Consult the specific conditions in the supplied material documentation.

Delivery and commercial terms

Freight, timing and import terms will be confirmed in the quote for the selected destination.